Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT06229236

Assessing Effectiveness of a Diabetes Navigator in Increasing Progression of Advanced Diabetes Technologies

Conditions: Diabetes Mellitus, Type 1

Sex: All
Ages: 5 Years – 75 Years
Healthy volunteers: No
Phase: NA
Enrollment: 148
Sponsor: Johns Hopkins University

Location: Johns Hopkins University School of Medicine Baltimore Maryland

Summary

The goal of this randomized control trial is to determine if the support of a Diabetes Navigator is more effective than standard care in improving uptake and use of advanced diabetes technology among patients with type 1 diabetes.

Eligibility Criteria

Inclusion Criteria: * Male or female aged 5 to 75 years. * Diagnosis of type 1 diabetes * Patient of Johns Hopkins Medicine adult or pediatric diabetes clinics * Not using or not optimally using diabetes technology. * Planned Diabetes technology intensification by diabetes provider. * If already on diabetes technology - must be using the specific device for a minimum of 14 days. Exclusion Criteria: * Optimally using Diabetes Technology * Pregnancy or lactation or planned pregnancy in the next 12 months. * Other types of diabetes (type 2 diabetes, Maturity Onset Diabetes in Youth, cystic fibrosis-related diabetes, steroid-induced diabetes, post total pancreatectomy, transplant-related diabetes) * Active participant of any other research study that may interfere with diabetes management.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06229236). StuddyBuddy aggregates publicly available trial information.